IMN || Cardiology

Intensive BP, lipid control didn’t alter cognitive decline in type 2 diabetes

Posted on: 03/02/2014 - 21:00

Neither intensive blood pressure control nor intensive lipid management slowed cognitive decline in adults with long-standing type 2 diabetes. Additionally, after 40 months, patients in the ACCORD...

Field of Interest: Endocrinology

Type: News Item

Intensive BP, lipid control didn’t alter cognitive decline in type 2 diabetes

Posted on: 03/02/2014 - 21:00

Neither intensive blood pressure control nor intensive lipid management slowed cognitive decline in adults with long-standing type 2 diabetes. Additionally, after 40 months, patients in the ACCORD...

Field of Interest: Geriatrics

Type: News Item

FDA investigating testosterone’s cardiovascular risks

Posted on: 03/02/2014 - 14:00

The Food and Drug Administration is reassessing the cardiovascular safety of approved testosterone treatments and urged physicians and patients to report side effects. Two recent observational...

Field of Interest: Cardiology

Type: News Item

FDA investigating testosterone’s cardiovascular risks

Posted on: 03/02/2014 - 14:00

The Food and Drug Administration is reassessing the cardiovascular safety of approved testosterone treatments and urged physicians and patients to report side effects. Two recent observational...

Field of Interest: Geriatrics

Type: News Item

WOEST results guide antithrombotic therapy in PCI

Posted on: 30/01/2014 - 13:55

SNOWMASS, COLO. – A recent randomized trial provides physicians with important new guidance on how to manage antithrombotic therapy in patients requiring oral anticoagulation who develop an acute...

Field of Interest: Cardiology

Type: News Item

CoreValve holds size advantage for U.S. TAVR

Posted on: 28/01/2014 - 21:10

When the Food and Drug Administration in January granted marketing approval to a second transcatheter aortic valve replacement system for inoperable patients with aortic stenosis, the CoreValve...

Field of Interest: Cardiology

Type: News Item

Former JNC 8 hypertension panel issues minority report

Posted on: 28/01/2014 - 17:15

The controversial hypertension-management guidelines released by the former JNC 8 panel in December was not the group’s last word. There was a minority report, too, published almost a month later in...

Field of Interest: Geriatrics

Type: News Item

Sound Off: How do you determine the appropriate interval for follow-up visits?

Posted on: 24/01/2014 - 21:20

Total United States health care costs could be lowered by billions of dollars per year if evidence-based guidelines for follow-up patient visits are established, according to the authors of a <link...

Field of Interest: Cardiology

Type: News Item

One health system cut diabetes events, with set patient measures and cash for physicians

Posted on: 23/01/2014 - 19:30

An incentivized, system-based approach to improve care for patients with diabetes and other chronic diseases appeared to pay off after just 3 years by significantly cutting the incidence of adverse...

Field of Interest: Endocrinology

Type: News Item

FDA approves dapagliflozin for type 2 diabetes

Posted on: 08/01/2014 - 20:20

Dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, has been approved for the treatment of type 2 diabetes with a requirement that the manufacturer conduct postmarketing studies that address...

Field of Interest: Endocrinology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters